Enterprise Account Executive, Aizon
Europe
Offers stock options
Data analysis for life sciences manufacturers
Job no longer available
Data analysis for life sciences manufacturers
101-200 employees
Job no longer available
Offers stock options
101-200 employees
Company mission
To bring safe, high quality and effective drugs to patients.
Role
Who you are
- Sales acumen - several years of experience selling enterprise software with a proven track record of meeting or exceeding quota
- Outstanding communication and presentations skills, including ability to build executive-level rapport and develop internal champions
- Life science industry and manufacturing experience - acronyms like ERP, MES, LIMS, QMS, GxP, eBR and historians are part of your daily conversations, and you are familiar with regulations and standards such as FDA 21CFR11, ISO 13484 and GAMP 5
- Entrepreneurial spirit with the hunger to succeed; act with a ownership mindset and have urgency, grit, and the willingness to get work done
- Curiosity - know how to ask the right questions and listen to understand, with outstanding oral and written communication skills
- Ability to work independently, as well as collaborative in a team environment across multiple geographies and time zones
- Willingness to travel on a frequent and regular basis, per business needs
- Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities simultaneously
What the job involves
- We are looking for ambitious new team members who are motivated to make a positive impact in the life science industry and share our values of: trust, customer-centricity, innovation, integrity, collaboration, and passion
- Reporting to the Chief Revenue Officer, the Enterprise Account Executive we are looking for is a highly motivated, ambitious and proactive sales professional that can successfully persuade a range of stakeholders at life science manufacturers to transform their operations with Aizon’s leading AI-powered SaaS platform
- We offer a unique opportunity for the right person to make a real difference on a small but ambitious team, including a direct path to impact the company’s growth journey
- Enterprise sales execution - identify and drive large, complex deals and own the entire value-based sales process from creation through the proposal, legal, procurement, negotiation, to closure
- Understand customer needs to effectively position Aizon as the preferred manufacturing platform across a range of C-level executives / senior-level positions, and convince prospective clients to partner with Aizon to improve their manufacturing operations
- Employ excellent client-facing communication skills to overcome obstacles, create strong stakeholder engagement and support, and present complex concepts in an easy to understand manner to both business and technical minded audiences
- Work closely with the Chief Revenue Office and the entire sales, product and consulting teams to develop account-based sales strategies and help continuously improve our sales playbook
- Meet or exceed quarterly and annual sales objectives per assigned territory and accounts, including development and execute of territory / account / opportunity sales plans
- Maintain accurate forecasts on a monthly / quarterly / annual basis
Our take
In the pharmaceutical manufacturing sector, arduous testing phases and lengthy clinical studies are a necessity. However, the development of urgent drugs is made even longer by inefficient data management and the slow optimisation of large-scale manufacturing processes.
Aizon is a company that serves pharmaceutical manufacturers with a GxP compliant predictive analytics platform. Its suite of solutions leverage industrialised AI to produce insights that can help improve processes, provide transparency, and deliver drugs quickly and on budget.
The company has seen funding to the sum of over $40 million, testament to the the value the industry sees in its proposition. Aizon’s most recent round of funding will be used to execute its strategic roadmap, which includes significant scaling and the acceleration of its development pipeline.
Freddie
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 4 rounds)
Feb 2024
$20m
SERIES C
Nov 2019
$15m
SERIES B
Total funding: $43.7m
Company benefits
- Stock options
- Health insurance
- Work life balance
- Continuous education
Company HQ
Financial District, San Francisco, CA
Leadership
Pep Gubau
(CEO & CTO)Previously CEO at gnuine and Physis.
Toni Manzano
(CSO)Currnetly Member of the Parenteral Drug Association, International Expert on 4IR in Biopharma for UNIDO, Lecturer at Universitat Rovira i Virgili, and Lecturer at OBS Business School.
Pere Merino
(Board Director)Currently Board Member and Director at Kiin, Chairman and Co-Founder at HONEXT. Previously Co-Founder at ABEMER&SONS, and Founder and President at Fundació Hope Projects.
Share this job